SCHEMBL7366485

SCHEMBL7366485

CCCCN1CCN2[C@H](Cc3c([nH]c4ccccc34)[C@@H]2c2ccc(C)cc2)C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 8/20 0.61
HDAC3 O15379 1/20 0.61
HDAC4 P56524 1/20 0.61
HDAC1 Q13547 1/20 0.61
HDAC7 Q8WUI4 1/20 0.61
HDAC2 Q92769 1/20 0.61
HDAC10 Q969S8 1/20 0.61
HDAC11 Q96DB2 1/20 0.61
HDAC8 Q9BY41 1/20 0.61
HDAC6 Q9UBN7 1/20 0.61
HDAC9 Q9UKV0 1/20 0.61
HDAC5 Q9UQL6 1/20 0.61
PDE11A Q9HCR9 2/20 0.49
ABCG2 Q9UNQ0 1/20 0.48
PDE6D O43924 1/20 0.47
PDE6A P16499 1/20 0.47
PDE6G P18545 1/20 0.47
PDE6B P35913 1/20 0.47
PDE6C P51160 1/20 0.47
PDE6H Q13956 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7423055 1.00 PDE5A (0.61) PDE5AHDAC3HDAC4HDAC1HDAC7
SCHEMBL7423061 1.00 PDE5A (0.61) PDE5AHDAC3HDAC4HDAC1HDAC7
SCHEMBL14104620 0.77 PDE5A (0.46) PDE5AHDAC3HDAC4HDAC1HDAC7
SCHEMBL7685541 0.74 MEN1 (0.51) PDE5AHDAC3HDAC4HDAC1HDAC7
SCHEMBL7685549 0.74 MEN1 (0.51) PDE5AHDAC3HDAC4HDAC1HDAC7
SCHEMBL1326138 0.73 PDE5A (0.85) PDE5A
SCHEMBL1326142 0.73 PDE5A (0.85) PDE5A
SCHEMBL1326139 0.73 PDE5A (0.85) PDE5A
SCHEMBL14104621 0.70 KMT2A (0.44) PDE5AHDAC3HDAC4HDAC1HDAC7
SCHEMBL7359519 0.69 PDE5A (0.60) PDE5APDE11APDE6DPDE6APDE6G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0740668-A1 TETRACYCLIC DERIVATIVES, PROCESS OF PREPARATION AND USE LABORATORIES GLAXO WELLCOME S.A. (FR) 1996-11-06 EP claimed
WO-1995019978-A1 TETRACYCLIC DERIVATIVES, PROCESS OF PREPARATION AND USE LABORATOIRES GLAXO WELLCOME S.A. (FR) 1995-07-27 WO claimed
EP-0839040-A1 USE OF CGMP-PHOSPHODIESTERASE INHIBITORS TO TREAT IMPOTENCE ICOS CORPORATION (US) 1998-05-06 EP disclosed
WO-1997003675-A1 USE OF CGMP-PHOSPHODIESTERASE INHIBITORS TO TREAT IMPOTENCE ICOS CORPORATION (US) 1997-02-06 WO disclosed